Global Specific Cancer Immunotherapy Drugs Market Research Report Forecast 2017-2021

May 2017 | 105 pages | ID: G8895A2C527EN
S&P Consulting

Abstracts

The Global Specific Cancer Immunotherapy Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Specific Cancer Immunotherapy Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Specific Cancer Immunotherapy Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

Global Specific Cancer Immunotherapy Drugs Market: Regional Segment Analysis

North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:

Amgen
Roche
Bristol Myers Squibb
Dendreon (Valeant)
Novartis
Seattle Genetics
Hangzhou Jinjiang Group
company 8
company 9

Global Specific Cancer Immunotherapy Drugs Market: Product Segment Analysis

Tablet
Injection
Type 3


Global Specific Cancer Immunotherapy Drugs Market: Application Segment Analysis

Leukemia Treatment
Colorectal Cancer Treatment
Other Cancer Treatment

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Global Specific Cancer Immunotherapy Drugs Market Research Report Forecast 2017-2021

CHAPTER 1 SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Specific Cancer Immunotherapy Drugs
1.2 Specific Cancer Immunotherapy Drugs Market Segmentation by Type
  1.2.1 Global Production Market Share of Specific Cancer Immunotherapy Drugs by Type in 2015
  1.2.1 Tablet
  1.2.2 Injection
  1.2.3 Type
1.3 Specific Cancer Immunotherapy Drugs Market Segmentation by Application
  1.3.1 Specific Cancer Immunotherapy Drugs Consumption Market Share by Application in 2015
  1.3.2 Leukemia Treatment
  1.3.3 Colorectal Cancer Treatment
  1.3.4 Other Cancer Treatment
1.4 Specific Cancer Immunotherapy Drugs Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Specific Cancer Immunotherapy Drugs (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON SPECIFIC CANCER IMMUNOTHERAPY DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 Global Specific Cancer Immunotherapy Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 Global Specific Cancer Immunotherapy Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Specific Cancer Immunotherapy Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Specific Cancer Immunotherapy Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Specific Cancer Immunotherapy Drugs Market Competitive Situation and Trends
  3.5.1 Specific Cancer Immunotherapy Drugs Market Concentration Rate
  3.5.2 Specific Cancer Immunotherapy Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Specific Cancer Immunotherapy Drugs Production by Region (2012-2017)
4.2 Global Specific Cancer Immunotherapy Drugs Production Market Share by Region (2012-2017)
4.3 Global Specific Cancer Immunotherapy Drugs Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Specific Cancer Immunotherapy Drugs Consumption by Regions (2012-2017)
5.2 North America Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Specific Cancer Immunotherapy Drugs Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Specific Cancer Immunotherapy Drugs Production and Market Share by Type (2012-2017)
6.2 Global Specific Cancer Immunotherapy Drugs Revenue and Market Share by Type (2012-2017)
6.3 Global Specific Cancer Immunotherapy Drugs Price by Type (2012-2017)
6.4 Global Specific Cancer Immunotherapy Drugs Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET ANALYSIS BY APPLICATION

7.1 Global Specific Cancer Immunotherapy Drugs Consumption and Market Share by Application (2012-2017)
7.2 Global Specific Cancer Immunotherapy Drugs Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS MANUFACTURERS ANALYSIS

8.1 Amgen
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Roche
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Bristol Myers Squibb
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Dendreon (Valeant)
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Novartis
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Seattle Genetics
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Hangzhou Jinjiang Group
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 company
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 company
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 SPECIFIC CANCER IMMUNOTHERAPY DRUGS MANUFACTURING COST ANALYSIS

9.1 Specific Cancer Immunotherapy Drugs Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Specific Cancer Immunotherapy Drugs Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET FORECAST (2017-2021)

13.1 Global Specific Cancer Immunotherapy Drugs Production, Revenue Forecast (2017-2021)
13.2 Global Specific Cancer Immunotherapy Drugs Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Specific Cancer Immunotherapy Drugs Production Forecast by Type (2017-2021)
13.4 Global Specific Cancer Immunotherapy Drugs Consumption Forecast by Application (2017-2021)
13.5 Specific Cancer Immunotherapy Drugs Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Specific Cancer Immunotherapy Drugs
Figure Global Production Market Share of Specific Cancer Immunotherapy Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Specific Cancer Immunotherapy Drugs Consumption Market Share by Application in 2015
Figure Leukemia Treatment Examples
Figure Colorectal Cancer Treatment Examples
Figure Other Cancer Treatment Examples
Figure North America Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Specific Cancer Immunotherapy Drugs Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Specific Cancer Immunotherapy Drugs Capacity of Key Manufacturers (2015 and 2016)
Table Global Specific Cancer Immunotherapy Drugs Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Specific Cancer Immunotherapy Drugs Capacity of Key Manufacturers in 2015
Figure Global Specific Cancer Immunotherapy Drugs Capacity of Key Manufacturers in 2016
Table Global Specific Cancer Immunotherapy Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Specific Cancer Immunotherapy Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Specific Cancer Immunotherapy Drugs Production Share by Manufacturers
Figure 2016 Specific Cancer Immunotherapy Drugs Production Share by Manufacturers
Table Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers
Table 2016 Global Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers
Table Global Market Specific Cancer Immunotherapy Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Specific Cancer Immunotherapy Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Specific Cancer Immunotherapy Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Specific Cancer Immunotherapy Drugs Product Type
Figure Specific Cancer Immunotherapy Drugs Market Share of Top 3 Manufacturers
Figure Specific Cancer Immunotherapy Drugs Market Share of Top 5 Manufacturers
Table Global Specific Cancer Immunotherapy Drugs Capacity by Regions (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Capacity Market Share by Regions (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Specific Cancer Immunotherapy Drugs Capacity Market Share by Regions
Table Global Specific Cancer Immunotherapy Drugs Production by Regions (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Production and Market Share by Regions (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Production Market Share by Regions (2012-2017)
Figure 2015 Global Specific Cancer Immunotherapy Drugs Production Market Share by Regions
Table Global Specific Cancer Immunotherapy Drugs Revenue by Regions (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue Market Share by Regions (2012-2017)
Table 2015 Global Specific Cancer Immunotherapy Drugs Revenue Market Share by Regions
Table Global Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table India Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Consumption Market by Regions (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Consumption Market Share by Regions (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Specific Cancer Immunotherapy Drugs Consumption Market Share by Regions
Table North America Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017)
Table India Specific Cancer Immunotherapy Drugs Production, Consumption, Import & Export (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Production by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Specific Cancer Immunotherapy Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Specific Cancer Immunotherapy Drugs by Type
Table Global Specific Cancer Immunotherapy Drugs Revenue by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Specific Cancer Immunotherapy Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Specific Cancer Immunotherapy Drugs by Type
Table Global Specific Cancer Immunotherapy Drugs Price by Type (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Production Growth by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Consumption by Application (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Consumption Market Share by Application (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Consumption Market Share by Application in 2015
Table Global Specific Cancer Immunotherapy Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Consumption Growth Rate by Application (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Specific Cancer Immunotherapy Drugs Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Roche Specific Cancer Immunotherapy Drugs Market Share (2012-2017)
Table Bristol Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Market Share (2012-2017)
Table Dendreon (Valeant) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Specific Cancer Immunotherapy Drugs Market Share (2012-2017)
Table Seattle Genetics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Seattle Genetics Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Seattle Genetics Specific Cancer Immunotherapy Drugs Market Share (2012-2017)
Table Hangzhou Jinjiang Group Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Market Share (2012-2017)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table company 8 Specific Cancer Immunotherapy Drugs Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Specific Cancer Immunotherapy Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Specific Cancer Immunotherapy Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Specific Cancer Immunotherapy Drugs
Figure Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs
Figure Specific Cancer Immunotherapy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Manufacturers in 2015
Table Major Buyers of Specific Cancer Immunotherapy Drugs
Table Distributors/Traders List
Figure Global Specific Cancer Immunotherapy Drugs Production and Growth Rate Forecast (2017-2021)
Figure Global Specific Cancer Immunotherapy Drugs Revenue and Growth Rate Forecast (2017-2021)
Table Global Specific Cancer Immunotherapy Drugs Production Forecast by Regions (2017-2021)
Table Global Specific Cancer Immunotherapy Drugs Consumption Forecast by Regions (2017-2021)
Table Global Specific Cancer Immunotherapy Drugs Production Forecast by Type (2017-2021)
Table Global Specific Cancer Immunotherapy Drugs Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Amgen, Roche, Bristol Myers Squibb, Dendreon (Valeant), Novartis, Seattle Genetics, Hangzhou Jinjiang Group